Share Facebook Twitter LinkedIn WhatsApp Pinterest Email Adaptimmune GAAP EPS -$0.03 beat $0.20, Revenue $11.03M beat $5.95M
Sanofi stock surges as Dupixent shows benefit in smokers with lung disease and meets Phase 3 goalsMarch 23, 2023
